Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
-
Jackson, Daniel J. (University of Wisconsin School of Medicine and Public Health)
;
Bacharier, Leonard B. (Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tennessee) ;
Phipatanakul, Wanda (Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts) ;
Sher, Lawrence (Peninsula Research Associates, Rolling Hills Estates, California.) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Papadopoulos, Nikolaos (University of Athens, Greece) ;
Modena, Brian (Modena Allergy & Asthma, La Jolla, California) ;
Li, Ning (Department of Immunology, Sanofi, Beijing, People's Republic of China) ;
Xia, Changming (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Kamal, Mohamed A. (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Dillon, Myles (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Wolfe, Kelley (Department of Immunology, Sanofi, Bridgewater, New Jersey) ;
Gall, Rebecca (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Amin, Nikhil (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Mannent, Leda P. (Department of Immunology, Sanofi, Chilly-Mazarin, France) ;
Laws, Elizabeth (Sanofi (Bridgewater, New Jersey)) ;
Rowe, Paul J. (Sanofi (Bridgewater, New Jersey)) ;
Jacob-Nara, Juby A. (Sanofi (Bridgewater, New Jersey)) ;
Deniz, Yamo (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Lederer, David J. (Regeneron Pharmaceuticals (Tarrytown, New York)) ;
Hardin, Megan (Sanofi (Cambridge, Estats Units d'Amèrica)) ;
Xu, Christine (Sanofi (Bridgewater, New Jersey)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina